The interplay of post-translational modification and gene therapy

dc.creatorOsamor, V. C., Chinedu, S. N., Azuh, Dominic E., Iweala, E. E. J., Ogunlana, Olubanke Olujoke
dc.date2016
dc.date.accessioned2025-03-29T18:24:01Z
dc.descriptionSeveral proteins interact either to activate or repress the expression of other genes during transcription. Based on the impact of these activities, the proteins can be classified into readers, modifier writers, and modifier erasers depending on whether histone marks are read, added, or removed, respectively, from a specific amino acid. Transcription is controlled by dynamic epigenetic marks with serious health implications in certain complex diseases, whose understanding may be useful in gene therapy. This work highlights traditional and current advances in post-translational modifications with relevance to gene therapy delivery. We report that enhanced understanding of epigenetic machinery provides clues to functional implication of certain genes/gene products and may facilitate transition toward revision of our clinical treatment procedure with effective fortification of gene therapy delivery
dc.formatapplication/pdf
dc.identifierhttp://eprints.covenantuniversity.edu.ng/7510/
dc.identifier.urihttps://repository.covenantuniversity.edu.ng/handle/123456789/36928
dc.languageen
dc.subjectQ Science (General), QA75 Electronic computers. Computer science
dc.titleThe interplay of post-translational modification and gene therapy
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
dddt-10-861.pdf
Size:
521.91 KB
Format:
Adobe Portable Document Format

Collections